In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections

International Journal of Antimicrobial Agents

Volumn 28, Issue 6, 2006, Pages 568-573

  Seidler, Marc ^a   Salvenmoser, Stefanie ^a   Müller, Frank Michael C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

DIC transmission light microscopy; Safranin staining; XTT

Indexed keywords

MICAFUNGIN; POLYSTYRENE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KEFYR; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; STAINING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, INTERFERENCE; PEPTIDES, CYCLIC; PHENAZINES; POLYSTYRENES; STAINING AND LABELING; TETRAZOLIUM SALTS;

EID: 33751182110     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.07.024     Document Type: Article

References (34)

1. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 11 (2003) 30-36
2. Ramage G., Saville S.P., Thomas D.P., and Lopez-Ribot J.L. Candida biofilms: an update. Eukaryot Cell 4 (2005) 633-638
3. Schierholz J.M., Beuth J., Rump A., Konig D.P., and Pulverer G. Novel strategies to prevent catheter-associated infections in oncology patients. J Chemother 13 Spec. No. 1 (2001) 239-250
4. Alem M.A., and Douglas L.J. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 48 (2004) 41-47
5. Alem M.A., and Douglas L.J. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54 (2005) 1001-1005
6. Baillie G.S., and Douglas L.J. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48 (1999) 671-679
7. Hawser S.P., Baillie G.S., and Douglas L.J. Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 47 (1998) 253-256
8. Kuhn D.M., George T., Chandra J., Mukherjee P.K., and Ghannoum M.A. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46 (2002) 1773-1780
9. Vogt M., Flemming H.C., and Veeman W.S. Diffusion in Pseudomonas aeruginosa biofilms: a pulsed field gradient NMR study. J Biotechnol 77 (2000) 137-146
10. Baillie G.S., and Douglas L.J. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob Agents Chemother 42 (1998) 2146-2149
11. Baillie G.S., and Douglas L.J. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 42 (1998) 1900-1905
12. Baillie G.S., and Douglas L.J. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310 (1999) 644-656
13. Hawser S.P., and Douglas L.J. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 39 (1995) 2128-2131
14. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 284 (1999) 1318-1322
15. Bachmann S.P., VandeWalle K., Ramage G., et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46 (2002) 3591-3596
16. Cocuaud C., Rodier M.H., Daniault G., and Imbert C. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56 (2005) 507-512
17. Kojic E.M., and Darouiche R.O. Comparison of adherence of Candida albicans and Candida parapsilosis to silicone catheters in vitro and in vivo. Clin Microbiol Infect 9 (2003) 684-690
18. Kojic E.M., and Darouiche R.O. Candida infections of medical devices. Clin Microbiol Rev 17 (2004) 255-267
19. Ramage G., Vande Walle K., Wickes B.L., and Lopez-Ribot J.L. Biofilm formation by Candida dubliniensis. J Clin Microbiol 39 (2001) 3234-3240
20. Ramage G., Vande Walle K., Wickes B.L., and Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45 (2001) 2475-2479
21. Klotz S.A., Drutz D.J., and Zajic J.E. Factors governing adherence of Candida species to plastic surfaces. Infect Immun 50 (1985) 97-101
22. Hawser S.P., and Douglas L.J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62 (1994) 915-921
23. Baillie G.S., and Douglas L.J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46 (2000) 397-403
24. Chandra J., Kuhn D.M., Mukherjee P.K., Hoyer L.L., McCormick T., and Ghannoum M.A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183 (2001) 5385-5394
25. Kuhn D.M., Chandra J., Mukherjee P.K., and Ghannoum M.A. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70 (2002) 878-888
26. Mukherjee P.K., Chandra J., Kuhn D.M., and Ghannoum M.A. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71 (2003) 4333-4340
27. Bandoni R.J. Safranin O as a rapid nuclear stain for fungi. Mycologia 11 (1979) 873-874
28. Chandra J., Mukherjee P.K., Leidich S.D., et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80 (2001) 903-908
29. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne, PA: NCCLS; 1997.
30. Lewis R.E., Kontoyiannis D.P., Darouiche R.O., Raad I.I., and Prince R.A. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 46 (2002) 3499-3505
31. Al-Fattani M.A., and Douglas L.J. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 48 (2004) 3291-3297
32. Akiyama H., Hamada T., Huh W.K., et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol 148 (2003) 526-532
33. Ramage G., Vandewalle K., Wickes B.L., and Lopez-Ribot J.L. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18 (2001) 163-170
34. Kuhn D.M., and Ghannoum M.A. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 5 (2004) 186-197